Lucida Medical

medical devices

About

Lucida Medical is a biotechnology company founded in 2019, led by CEO Dr. Antony Rix and Chief Medical Officer Professor Evis Sala. Based in Cambridge, England, the company specializes in AI-driven medical imaging technology aimed at cancer detection and diagnosis. The flagship product, Pi™ (Prostate Intelligence), is an AI-based software that analyzes MRI scans with high accuracy to assist clinicians in screening, diagnosing, and treating prostate cancer. This technology is trained on diverse datasets, allowing it to identify prostate cancer with precision comparable to expert radiologists. Lucida Medical's solutions are designed to enhance diagnostic accuracy, reduce unnecessary tests, and support early detection and optimized treatment for patients. Lucida Medical collaborates with healthcare providers, including NHS hospitals and cancer centers, to validate and implement its AI tools in clinical settings. The company's focus is on improving patient outcomes through advanced imaging analysis and efficient cancer detection.

Technologies

MailJet Outlook GitLab Mobile Friendly WordPress.org Vimeo Google Tag Manager Google Font API AI

Keywords

medical device artificial intelligence reporting medical imaging mri machine learning image enhancement oncology cancer diagnosis cancer screening radiology medical ai partnerships ai diagnostics clinical validation ai for cancer grading biopsy reduction risk scoring biopsy decision support diagnostic support healthcare technology multi-center research ai prostate cancer diagnosis b2b early diagnosis cancer detection ai risk stratification liquid biomarkers integration government prostate cancer detection ai surgical planning

Location

Kings Hedges Road, Cambridge, England, United Kingdom, CB4 2HY

Related Companies

Companies in the same industry